Structural aspects of the erythrocyte membrane;Aspectos estruturais da membrana eritrocitária

Revista Brasileira de Hematologia e Hemoterapia

Volumn 29, Issue 2, 2007, Pages 168-178

  Murador, Priscila ^a,b,d   Deffune, Elenice ^a,c  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b Hemocentro de Botucatu ^*  (Brazil)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antigens; Erythrocyte membrane; Glycophorins; Proteins

Indexed keywords

EID: 37349025482     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-84842007000200016     Document Type: Review

References (31)

1. Salmon C, Cartron JP, Rouger P . The human blood groups part1. New York: Masson Publishing USA; 1984. cap. 4, p.44-53.
2. Wajcman H, Lantz B, Girot R. Les Maladies du globule rouge. Paris: Les editions INSERM. Médecine-Sciences Flammarion;1984. cap. 3, p.31-44.
3. Cooper GM. The cell surface In: The cel: A molecular approach. Washington: ASM Press 1997. p.467-517.
4. Matei H, Frentescu L, Benga Gh. Comparative studies of the protein composition of red blood cell membranes from eight mammalian species. J Cell Mol Med. 2000;4:270-80.
5. Gallager PG, Forget BG, Lux SE. Disorders of Erythrocyte Membrane. In: Nathan DG, Oski FA, Orkin SH. Hematology of Infancy and Childhood. 5 ed. Philadelphia: WB Saunders; 1998. p.544-664.
6. Zhang D, Kiyatkin A, Bolin JT, Low PS. Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3. Blood. 2000;96:2925-33.
7. Jarolin P, Rubin HL, Zakova D, Storry J, Reid ME. Characterization of seven low incidence blood group carried by erythrocyte band 3 protein. Blood. 1998;92:4836-43.
8. Storry J. A review: modification of red blood membrane and its application in blood groups serology. Immunology. 2000;16(3):3-5.
9. Telen MJ, Kaufman R. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B - Wintrobés Clinical Hematology. 11th ed. Philadelphia: Lippincott William & Wilkins; 2003. v. 1, cap. 8, p.217-47.
10. Blackman SM, Hustedt EJ, Cobb CE, Beth AH. Flexibility of the cytoplasmic domain of the anion exchange protein, band 3, in human erythrocytes. Biophys J. 2001;81:3363-76.
11. Saad STO. Anemias por defeitos de membrana eritrocitária. In: Zago MA, Falcão RP, Pasquim R. Hematologia: fundamentos práticos. São Paulo: Atheneu; 2001. cap 26. p.250-264.
12. Mandal D, Baudin-Creuza V, Bhattacharyya A, Pathak S, Delaunay J, Kundu M, Basu J. Caspase 3-mediated proteolysis of the N-terminal cytoplasmic domain of the human erythroid anion exchanger 1 (band 3). J Biol Chem. 2003;278(52):52551-8.
13. Fu G, Wang T, yang B, Lv F, Shi C, Jiang X, et al. Purification and characterization of human erythrocyte band 3 protein C- terminal domain. Biochemistry. 2004;43:1633-8.
14. Wong P. A basis of the acanthocytosis in inherited and acquired disorders. Med Hypotheses. 2004;62:966-9.
15. Cheidde L, Vieira TC, Lima PRM, Saad STO, Heilberg IP. A novel mutation in the anio exchanger 1 gene is associated with familial distal renal tubular acidosis and nephocalcinosis. Pediatrics. 2003;112:1361-7.
16. Zdebska E, Bader-Meunier B, Schischmanoff PO, Dupre T, Seta N, Tchernia G, et al. Abnormal glycosylation of red cell membrane band 3 in the congenital disorder of glycosylation Ig. Pediatr Res. 2003;54(2):224-9.
17. Reliene R, Mariani M, Zanella A, Reinhart WH, Ribeiro ML, del Giudice EM. Splenectomy prolongs in vivo survival of erythrocytes differently in spectrin/ankyrin- and band 3-deficient hereditary spherocytosis. Blood. 2002;100:2208-15.
18. Oldenborg PA. Role of CD47 in erythroid cells and in autoimmunity. Leuk Lymphoma. 2004;45:1319-27.
19. Auffray I, Martafia S, Jong L, Lee G, Huang C, Pasztyet C, et al. Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice. Blood. 2001;97:2872-8.
20. Hassoun H, Hanada T, Lutchman M, Sahr KE, Palek J, Hanspal M, et al. Complete deficiency of glycophorin A in red blood cells from mice with targeted inactivation of band 3 (AE1) gene. Blood. 1998;91:2146-51.
21. Poole J, Banks J, Bruce LJ, Ring SM, Levene C, Stern H, et al. Glycophorin A mutation Ala65 - Pro gives rise to a novel pair of MNS alleles ENEP (MNS39) and HAG (MNS41) and altered Wrb expression: direct evidence for GPA/band 3 interaction necessary for normal Wrb expression. Transfusion Med. 1999;9:167-74.
22. Garraty G, Telen MJ, Petz LD. Red cell antigens as functional molecules and obstacles to transfusion. Hematology. 2002;445-62.
23. Lobo CA, Rodriguez M, Reid M, Lustigman S. Glycophorin C is the receptor for the Plasmodium falciparum erythrocyte binding ligand PfEBP-2 (baebl). Blood. 2003;101:4628-31.
24. Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, DuBell WH, et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature. 2003;421:587:589-90.
25. Gascard P, Nunomura W, Lee G, Walensky LD, Krauss SW, Takakuwa Y, et al. Deciphering the nuclear import pathway for the cytoskeletal red cell protein 4.1R. Mol Biol Cell. 1999;10:1783-98.
26. Terada N, Ohno N, Yamakawa H, Baba T, Fujii Y, Zea Z, et al. Immunohistochemical study of protein 4.1B in the normal and W/W(v) mouse seminiferous epithelium. J Histochem Cytochem. 2004;52:769-77.
27. Hemming NJ, Anstee DJ, Staricoff MA, Tanner MJA, Mohandas N. Identification of the membrane attachment sites for protein 4.1 in the human erythrocyte. J Biol Chem. 1995;270:5360-6.
28. Karacay B, Chang LS. Induction of erythrocyte protein 4.2 gene expression during differentiation of murine erythroleukemia cells. Genomics. 1999;59:6-17.
29. Horne WC, Miettinen H, Marchesi VT. Erythrocyte membrane skeleton phosphoprotein: identification of two unrelated phosphoprotein in band 4.9. Biochim Biophys Acta. 1988;944:135-43.
30. Faquin WC, Husain A, Hung J, Branton D. An immunoreactive form of erythrocyte protein 4.9 is present in non-erythroid cells. Eur J Cell Biol. 1988;46:168-75.
31. Peri, S. et al. Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Research. 2003;13:2363-71.